Cours InVitro International Other OTC
Actions
IVRO
US4618531036
Produits pharmaceutiques
CA 2022 | 854 k 780 k | CA 2023 | 793 k 724 k | Capitalisation | 1,3 M 1,19 M |
---|---|---|---|---|---|
Résultat net 2022 | - 0 | Résultat net 2023 | - 0 | VE / CA 2022 | 0,29 x |
Trésorerie nette 2022 | 1,23 M 1,13 M | Trésorerie nette 2023 | 1,13 M 1,03 M | VE / CA 2023 | 0,22 x |
PER 2022 |
69,3
x | PER 2023 |
885
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 96,73% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
W. Ulmer
CEO | Chief Executive Officer | - | 15/09/19 |
Cathy Richmond
DFI | Director of Finance/CFO | - | 15/09/19 |
Atul Jhalani
PSD | President | - | 03/06/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Irwin Gruverman
BRD | Director/Board Member | 89 | 23/09/20 |
Dennis Chenoweth
BRD | Director/Board Member | - | - |
W. Ulmer
CEO | Chief Executive Officer | - | 15/09/19 |
Varia. 1 janv. | Capi. | |
---|---|---|
+25,83% | 661 Md | |
+27,00% | 566 Md | |
-6,76% | 352 Md | |
+20,34% | 332 Md | |
+3,00% | 283 Md | |
+13,09% | 231 Md | |
+5,46% | 200 Md | |
-9,61% | 195 Md | |
-6,26% | 145 Md |